Third, we performed RT-qPCR validation in peripheral blood samples from AD patients, which confirmed the upregulation of NMB, IL2RA, IL1RL1, and PRKCQ, further supporting the MR-based predictions. This evidence concerns the gene PRKCQ and Alzheimer disease.